Clinical Formulary · MP-ORF-CAP-08
Orforglipron (NEW) with Chromium Picolinate 1mg / 0.8mg (30 Capsules)
Orforglipron (NEW) 1mg/0.8mg with Chromium Picolinate — 30 capsules, introductory.
SKU
MP-ORF-CAP-08
Form
glp capsules
Category
glp weight loss capsules
Status
In Stock
SKU: MP-ORF-CAP-08
Order This Product
Orforglipron (NEW) 1mg/0.8mg with Chromium Picolinate — 30 capsules, introductory.
Orforglipron (NEW) oral capsule — titrate to next strength per clinic schedule after tolerance confirmed.
Key Benefits
- NEW: Orforglipron oral GLP-1 RA
- Non-peptide oral agonist
- Entry strength 0.8mg
- Chromium Picolinate blend
Orforglipron is a novel oral non-peptide GLP-1 receptor agonist — an exciting addition to clinic weight management formularies. Entry strength with Chromium Picolinate, 30 capsules.
$120.00
Professional clinical use only. Terms & conditions apply.
Product Solution Guide
Clinical Use & Administration
Non-injection weight management option for patients suited to oral daily dosing under clinical monitoring.
Follow your clinic's approved protocol. Steps below are general guidance for qualified practitioners.
- 1
Select Strength
Dispense the physician-prescribed strength (listed on bottle label). Match capsule strength to current titration phase of patient protocol.
- 2
Daily Oral Dose
Patient takes one capsule daily with a full glass of water, preferably at the same time each day. May take with or without food per clinic protocol.
- 3
Titration Schedule
Advance to next strength tier only per physician-directed schedule — typically after 4–8 weeks at current dose if tolerated.
- 4
Monitor & Reorder
Track 30-day supply per bottle. Schedule follow-up before bottle completion to avoid treatment gaps.
Clinic Ordering Notes
Order by strength tier. Multi-strength inventory recommended for active titration clinics.